Latest From Swecure AB
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups.
This Month's Profile Groups: Biopharma In Sweden, features profiles of Northern Light Pharmaceuticals, Sigrid Therapeutics, and Swecure; ENT Devices features profiles of Aerin Medical, ENTvantage Diagnostics, Fiagon, and Spirox. Plus these Start-Ups Across Health Care: Anagnostics Bioanalysis, Check-Cap, Edico Genome, G1 Therapeutics, HeadSense Medical, Innovent Biologics, Navitor Pharmaceuticals, Onciomed, and RevMedx.
There are many treatments on the market and in development that ease the symptoms of allergies, from antihistamines to immunotherapies, but there is no real prevention or cure. Swedish biotech Swecure AB aims to prevent the development of allergies in the first place: its research is based on a bacterial protein, known as a superantigen, found in the gut flora of newborn babies.
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups. Profiles of Northern Light Pharmaceuticals AB, Sigrid Therapeutics, and Swecure AB.
- Therapeutic Areas
- Immune Disorders
- Western Europe
- Parent & Subsidiaries
- Swecure AB
- Senior Management
Lars Fahlen, CEO
Alf Lindberg, MD, PhD, CSO
- Contact Info
Phone: 70 247 89 88
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.